Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality

Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality

Saved in:
Bibliographic Details
Published in:Bone marrow transplantation (Basingstoke) Vol. 51; no. 5; pp. 725 - 727
Main Authors: Inoue, Y, Fuji, S, Tanosaki, R, Fukuda, T
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-05-2016
Nature Publishing Group
Subjects:
692/699/67/1990/291/1621/1916
Bone marrow
Cancer
Care and treatment
Cell Biology
Chemotherapy
Development and progression
Graft-versus-host reaction
Health aspects
Hematology
Internal Medicine
Japan
letter-to-the-editor
Leukemia
Medicine
Medicine & Public Health
Monoclonal antibodies
Mortality
Patient outcomes
Public Health
Stem cell transplantation
Stem Cells
T cells
Japan
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2015.315